Cancer comes in many forms, and it affects the organs of the body such as the lungs, the colon, the prostate and the breast. This illness is feared by many because of its complexity. One of the best ways for dealing with cancer is early diagnosis. Some forms of cancer grow at a slow rate while other forms grow more rapidly. Cancer research has given society a better understanding about this deadly disease and Seattle Genetics just so happens to be one of those institutions. This oncology biotech company has been around since the late 1990s, and it has helped to revolutionize cancer research.
Dr. Clay Siegall is the founder, the president and the chief executive officer here. This extraordinary man is one of the most well-accomplished professionals in the world, especially when it comes to this specific field of work. He has worked with some of the biggest organizations in the business including the National Institute of Health, the National Cancer Institute and Bristol-Myers Squibb. The world of cancer research has made astounding gains in genetic testing, which has resulted in a reduced cost in genetic-sequencing. A person’s DNA code is made-up of an estimated 20,000 genes and every person’s DNA code is different from the next person. This gives cancer researchers a better understanding to why the disease affects each person in different ways. Thanks to the advancements, extracting the DNA code is possible and a person’s genetics can predispose him or her to certain forms of cancer.
Research also shows that the environment and your diet can play a critical factor in developing certain illnesses like cancer. Dr. Siegall knows this all too well because he has experienced the devastating effects of cancer via a family member. He has vowed to make cancer research his life’s work and as of today, he has done a wonderful job by bringing new advancements to the forefront.